• Home

The Chest Center

Head of department - Pr Nicolas Girard

Institut du thorax Curie - Montsouris 

01 44 32 46 06 - contact@thoraxparis.fr 

 

Institut Curie          Institut Mutualiste Montsouris

26 rue d’Ulm          42 bd Jourdan

75005 Paris            75014 Paris

Institut du thorax

Deux centres experts s’unissent pour créer l’Institut du Thorax Curie-Montsouris afin de proposer aux patients une prise en charge globale, sous la responsabilité du Pr Nicolas Girard. Cet institut regroupe, sur deux sites hospitaliers, le département de pneumologie et de chirurgie thoracique de l'Institut Mutualiste Montsouris et les départements d'oncologie médicale et d’oncologie radiothérapique de l'Institut Curie.

What is the Chest Center?

The Curie-Montsouris Chest Center is a center of excellence for patients suffering from lung cancer and other chest diseases, whether with tumor or not. By pooling our skills and expertise from the two Institutes, we provide seamless care, from screening to diagnosis, treatment and follow-up.

Each stage of treatment benefits from a multi-disciplinary approach, bringing together all the specialist practitioners to achieve individualized treatment that incorporates all relevant therapies and innovations. The patient files are discussed in a multidisciplinary consultation meeting (RCP) attended by all practitioners at the Chest Center (pneumologists, oncologists, radiotherapists, chest surgeons, radiologists, anatomopathologists, nuclear physicians, anesthesiologists, etc.).

The institute is also involved in teaching and research, both basic and clinical. It offers patients the opportunity to access the latest innovations (medical or surgical) and to take part in clinical trials.

The Chest Center healthcare offering

The healthcare offering at the Chest Center involves the expertise of the departments described below, located on the two Parisian hospital sites at Institut Mutualiste Montsouris and Institut Curie.

Pulmonology (Montsouris site)

  • Treatment of respiratory diseases (lung cancer, respiratory failure, infectious diseases, thromboembolic diseases, etc.) 
  • Interventional respiratory medicine: rigid bronchoscopy: clearing and placement of tracheobronchial prosthesis 
  • Specialized endoscopy: fiberoptic endoscopy, endobronchial ultrasound (EBUS), mini-probe, electro-navigation (pulmonary GPS) 
  • Treatment of pleural diseases 
  • Functional respiratory explorations

Thoracic Surgery (Montsouris site)

  • Lung-cancer surgery 
  • Surgery on tumors of the trachea, the mediastinum (tumors, thymus, cysts, etc.) of the wall and the pleura 
  • Surgery on pulmonary metastases 
  • Chest wall deformation surgery 
  • Minimally-invasive surgery: video-assisted (thoracoscopy), robot-assisted, endobronchial electro-navigation assisted (pulmonary GPS).

Thoracic Medical Oncology (Curie site)

  • Chemotherapy, targeted therapies, immunotherapy. Treatment is offered in the day hospital with conventional hospitalization, or at the clinical investigation unit.

Radiotherapy (Curie site)

  • Intensity-modulated conformal radiotherapy
  • Tomotherapy and protontherapy
  • Radiotherapy in stereotaxic conditions

Imaging (on both sites)

  • Computed tomography
  • MRI
  • Diagnostic (guided biopsies) and therapeutic (radiofrequency) interventional radiology
  • Nuclear medicine: tomography (PET scan) and scintigraphy

Diagnostic and Theranostic Medicine Division (on both sites)

  • Anatomy and pathological cytology
  • Somatic and constitutional genetics
  • Clinical immunology
  • Biological resource center

Research

  • Clinical investigation unit (early trials, therapeutic trials, immunotherapy)
  • Basic research
  • Clinical immunology
  • Biological resource center

The Curie-Montsouris Chest Center brings together the skills of the Thoracic Surgery and Pulmonology Departments of Institut Mutualiste Montsouris and the Thoracic Oncology and Radiotherapy Departments of Institut Curie. Its goal is to treat patients suffering from cancer or any other chest disease, by offering optimum quality of care with first-rate access to diagnostic and therapeutic innovations and research.